6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T1448L | Dasatinib monohydrate | BMS-354825 Monohydrate | Apoptosis , Bcr-Abl , Src , c-Kit , Ephrin Receptor , Autophagy |
Dasatinib monohydrate (BMS-354825 Monohydrate) is an orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib monohydrate binds to and inhibits the growth-promoting activit... | |||
T18750 | N-Deshydroxyethyl Dasatinib | N-Deshydroxyethyl BMS-354825 | Others , IAP , Drug Metabolite |
N-Deshydroxyethyl Dasatinib (N-Deshydroxyethyl BMS-354825) is a metabolite of Dasatinib, a dasatinib-based molecule that degrades ABL by binding to the IAP ligand via a linker to form SNIPER.N-Deshydroxyethyl Dasatinib i... | |||
T22303 | Dasatinib hydrochloride | BMS-354825 HCl | Bcr-Abl , Src , c-Kit |
Dasatinib hydrochloride (BMS-354825 HCl) (BMS-354825) hydrochloride is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bc... | |||
T1448 | Dasatinib | BMS-354825 | Apoptosis , Bcr-Abl , Src , c-Kit , Autophagy |
Dasatinib (BMS-354825) is a tyrosine kinase inhibitor that inhibits Src and Bcr-Abl (Ki=16/30 pM) and is orally active and ATP-competitive. Dasatinib has antitumor activity and is used in the treatment of leukemia and ly... | |||
T18595 | Dasatinib carbaldehyde | PROTAC ABL binding moiety 4,BMS-354825 carbaldehyde | Others , Ligands for Target Protein for PROTAC |
Dasatinib carbaldehyde (PROTAC ABL binding moiety 4) is based on Dasatinib which is an ABL inhibitor, binds to the IAP ligand via a linker, and forms SNIPER [1]. | |||
T10962 | Dasatinib-d8 | BMS-354825 D8 | Others |
Dasatinib D8 is deuterium-labeled dasatinib. Dasatinib is a dual Bcr-Abl and Src family tyrosine kinase inhibitor. |